Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Outcome of Intra-amniotic DIGOXIN Injection for Feticide Prior to Second Trimester Abortion

NCT01951079 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT01951079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01951079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Outcome of Intra-amniotic DIGOXIN Injection for Feticide Prior to Second Trimester Abortion
Lead sponsor
Meir Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2013
Completion date
December 31, 2014
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, ecg changes, hypotension